Equity Details
Price & Market Data
Price: $0.05
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,388,350
Daily Volume: 0
Performance Metrics
1 Week: -7.41%
1 Month: -37.50%
3 Months: %
6 Months: 42.86%
1 Year: -44.44%
YTD: 82.82%
About Rafarma Pharmaceuticals, Inc. (RAFA)
Get insights into Rafarma Pharmaceuticals, Inc. (RAFA)'s financial health. With a price of 0.05, the stock shows a $0.00 / 0.00% daily change. Its market cap is 4,388,350. Detailed performance for 1-month (-37.50%) and 52-week (-44.44%) periods are crucial.
Details
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.